The US regulatory process involves three main phases of clinical trials, and according to a recent MIT study, only 13.8 percent of candidate drugs make it all the way through to FDA approval.[5] The ultimate result is a process that typically takes a decade to bring a new drug to market, at an average cost estimated between $1.3 billion and $2.6 billion.[6]
